Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026)
Cytosorbents' (CTSO) quarterly Exchange Rate Effect came in at $176000.0 in Q2 2026, down 31.52% on a YoY basis from $257000.0 in Q2 2025, and up 177.19% quarter-over-quarter from -$228000.0 in Q1 2026.
Powered by 
Analysis
Cytosorbents (CTSO) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Cytosorbents (CTSO) has reported Exchange Rate Effect for 14 consecutive years, with $176000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Exchange Rate Effect fell 31.52% year-over-year to $176000.0; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (up 336.74% YoY), and the FY2025 full-year result was $1.5 million, up 1852.94% from the prior year.
- Exchange Rate Effect climbed to $176000.0 in Q2 2026 per CTSO's latest filing, from -$228000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $1.4 million in Q4 2025 and bottomed at -$228000.0 in Q1 2026.
- Historically, Exchange Rate Effect has averaged $55017.1 across 5 years, with a median of -$14610.5 in 2023.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 3150.12% in 2022, then surged 1374.53% in 2025.
- Over 5 years, Exchange Rate Effect stood at $138734.0 in 2022, then slumped by 171.05% to -$98564.0 in 2023, then decreased by 7.54% to -$106000.0 in 2024, then soared by 1374.53% to $1.4 million in 2025, then tumbled by 86.97% to $176000.0 in 2026.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $176000.0, -$228000.0, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 4.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 7.10 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -89.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -14.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 1.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 3.80 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -4.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -2.30 Mn |
| 10 | Cytosorbents | 20.00 Mn | 15.59 Mn | 7.05 Mn | 176,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 176,000.00 |
| Mar 31, 2026 | -228,000.00 |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | -146,000.00 |
| Jun 30, 2025 | 257,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | -106,000.00 |
| Sep 30, 2024 | 85,000.00 |
| Jun 30, 2024 | -69,782.00 |
| Mar 31, 2024 | 5,782.00 |
| Dec 31, 2023 | -98,564.00 |
| Sep 30, 2023 | 23,143.00 |
| Jun 30, 2023 | -35,003.00 |
| Mar 31, 2023 | 10,655.00 |
| Dec 31, 2022 | 138,734.00 |
| Sep 30, 2022 | -160,491.00 |
| Jun 30, 2022 | -133,759.00 |
| Mar 31, 2022 | -107,408.00 |
| Dec 31, 2021 | 27,592.00 |
| Sep 30, 2021 | -4,938.00 |